February 3, 2021 — Hormone therapy commonly is given as a targeted treatment for women whose cancer cells carry receptors for estrogen. But the therapy only works for about half of all patients. Until now, there hasn't been a good way to reliably predict who will benefit and who will not.

February 2, 2021 — Volpara Health, a health technology software company whose integrated breast care platform assists in the delivery of personalized patient care, announced the acquisition of CRA Health, LLC, a breast cancer risk assessment company spinoff from Massachusetts General Hospital — a Harvard Medical School teaching hospital.

February 1, 2021 — COVID-19 vaccine distribution has begun across the globe, while many countries are still struggling with the rampant rise of infections.

January 29, 2021 — A nationwide panel of experts has developed the first mammography guidelines for older survivors of breast cancer, providing a framework for discussions between survivors and their physicians on the pros and cons of screening in survivors' later years.

January 29, 2021— Hologic, Inc. announced the expansion of its ultrasound portfolio with the launch of the new SuperSonic MACH 20 ultrasound system. Hologic now offers three tiers of ultrasound technology, ensuring more facilities have access to customized ultrasound solutions to address their unique imaging needs. Each of the systems is designed to increase efficiency and diagnostic accuracy, features exceptional image quality and innovative imaging modes, and offers an intuitive user experience.